• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 24 of 37
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
HealthSick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
By Lars Erik Taraldsen, Naomi Kresge and BloombergJanuary 15, 2021
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
HealthDrugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By James Paton and BloombergJanuary 13, 2021
Pfizer Moderna COVID vaccines
HealthWhat we know about which COVID vaccine you’ll receive
By Sy MukherjeeJanuary 12, 2021
Health Workers Administer Covid-19 Vaccines At Bronx Nursing Home
HealthPfizer and BioNTech’s overlooked third partner will distribute the vaccine in China—and it’s facing some resistance
By Grady McGregorJanuary 9, 2021
Pfizer BioNTech vaccine may be effective against fast-spreading COVID-19 variants, study says
HealthPfizer BioNTech vaccine may be effective against fast-spreading COVID-19 variants, study says
By Jeff Sutherland, Jason Gale and BloombergJanuary 8, 2021
The most vocal group condemning the violence at the Capitol just might be CEOs
LeadershipThe most vocal group condemning the violence at the Capitol just might be CEOs
By Clifton LeafJanuary 6, 2021
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
HealthEU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
By Naomi Kresge and BloombergJanuary 6, 2021
An Israeli military medic gets vaccinated against the COVID-19 coronavirus at the medical centre of Tzrifin military base in the Israeli town of Rishon Lezion on December 28, 2020.
HealthIsrael built the world’s best COVID vaccination program, but that’s unlikely to save it from new lockdown measures
By David MeyerJanuary 5, 2021
EU seeks an additional 300 million Pfizer-BioNTech vaccine doses
HealthEU seeks an additional 300 million Pfizer-BioNTech vaccine doses
By Naomi Kresge, John Follain and BloombergJanuary 5, 2021
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
HealthAstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By Viren Vaghela, Thomas Penny and BloombergDecember 28, 2020
Pfizer to supply U.S. with 100 million more vaccine doses
HealthPfizer to supply U.S. with 100 million more vaccine doses
By John Lauerman, Riley Griffin and BloombergDecember 23, 2020
COVID vaccine allergies
HealthCOVID vaccine allergies are raising concerns. Most Americans should still get their shots
By Sy MukherjeeDecember 19, 2020
Pfizer, Trump, and Biden: A twisted triangle that’s complicating COVID-19 relief
PoliticsPfizer, Trump, and Biden: A twisted triangle that’s complicating COVID-19 relief
By Nicole GoodkindDecember 18, 2020
How hackers could undermine a successful vaccine rollout
HealthHow hackers could undermine a successful vaccine rollout
By David Z. MorrisDecember 18, 2020
How hospitals are prioritizing who to give COVID vaccines to first
HealthHow hospitals are prioritizing who to give COVID vaccines to first
By Sy MukherjeeDecember 15, 2020
1...
  • 22
  • 23
  • 24
  • 25
  • 26
...37
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.